Melvin Gaskins

537 total citations
8 papers, 435 citations indexed

About

Melvin Gaskins is a scholar working on Oncology, Molecular Biology and Sociology and Political Science. According to data from OpenAlex, Melvin Gaskins has authored 8 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Sociology and Political Science. Recurrent topics in Melvin Gaskins's work include Global Cancer Incidence and Screening (4 papers), Prostate Cancer Treatment and Research (2 papers) and Family Support in Illness (2 papers). Melvin Gaskins is often cited by papers focused on Global Cancer Incidence and Screening (4 papers), Prostate Cancer Treatment and Research (2 papers) and Family Support in Illness (2 papers). Melvin Gaskins collaborates with scholars based in United States. Melvin Gaskins's co-authors include Robert L. DeWitty, Lucile L. Adams‐Campbell, Robert Gooding, Chiledum Ahaghotu, Fitzroy W. Dawkins, Duane T. Smoot, Henry C. Pitot, Winston Tan, Elisabeth I. Heath and David W. Hillman and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Oncology nursing forum.

In The Last Decade

Melvin Gaskins

8 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melvin Gaskins United States 6 162 133 125 63 56 8 435
R. Twombly 11 99 0.6× 85 0.6× 181 1.4× 60 1.0× 28 0.5× 72 512
Margaret Foti United States 10 139 0.9× 84 0.6× 231 1.8× 58 0.9× 46 0.8× 14 581
J. de Jong Switzerland 12 131 0.8× 155 1.2× 116 0.9× 32 0.5× 48 0.9× 15 420
Paula Trahan Rieger United States 13 115 0.7× 128 1.0× 221 1.8× 53 0.8× 101 1.8× 45 652
Melvin Chin Australia 11 83 0.5× 72 0.5× 203 1.6× 50 0.8× 61 1.1× 34 419
Lisa Stevens United States 12 166 1.0× 71 0.5× 327 2.6× 45 0.7× 51 0.9× 26 676
Carolina Wiesner Colombia 15 135 0.8× 92 0.7× 221 1.8× 12 0.2× 83 1.5× 64 660
Katherine Y. Tossas United States 9 75 0.5× 66 0.5× 285 2.3× 152 2.4× 66 1.2× 30 589
Luisel Ricks‐Santi United States 14 181 1.1× 71 0.5× 187 1.5× 108 1.7× 25 0.4× 42 526
Alison Smith United Kingdom 11 276 1.7× 91 0.7× 199 1.6× 61 1.0× 56 1.0× 26 761

Countries citing papers authored by Melvin Gaskins

Since Specialization
Citations

This map shows the geographic impact of Melvin Gaskins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvin Gaskins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvin Gaskins more than expected).

Fields of papers citing papers by Melvin Gaskins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melvin Gaskins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvin Gaskins. The network helps show where Melvin Gaskins may publish in the future.

Co-authorship network of co-authors of Melvin Gaskins

This figure shows the co-authorship network connecting the top 25 collaborators of Melvin Gaskins. A scholar is included among the top collaborators of Melvin Gaskins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melvin Gaskins. Melvin Gaskins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Copeland, Robert, Luisel Ricks‐Santi, Melvin Gaskins, et al.. (2017). Breast Cancer Prognosis for Young Patients. In Vivo. 31(4). 661–668. 9 indexed citations
2.
Adams‐Campbell, Lucile L., Kepher H. Makambi, Wayne Frederick, et al.. (2009). Breast Cancer Risk Assessments Comparing Gail and CARE Models in African-American Women. The Breast Journal. 15. S72–S75. 22 indexed citations
3.
Heath, Elisabeth I., David W. Hillman, Ulka N. Vaishampayan, et al.. (2008). A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer. Clinical Cancer Research. 14(23). 7940–7946. 154 indexed citations
4.
Heath, Elisabeth I., David W. Hillman, Ulka N. Vaishampayan, et al.. (2007). A phase II trial of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in patients with hormone-refractory metastatic prostate cancer. Journal of Clinical Oncology. 25(18_suppl). 15553–15553. 4 indexed citations
5.
Fogel, Joshua, et al.. (2006). African American women with breast cancer and their spouses' perception of care received from physicians.. PubMed. 17(1). 32–7. 2 indexed citations
6.
Fogel, Joshua, et al.. (2005). African American Couples Merging Strengths to Successfully Cope With Breast Cancer. Oncology nursing forum. 32(5). 979–987. 32 indexed citations
7.
Heath, Elisabeth I., Melvin Gaskins, Henry C. Pitot, et al.. (2005). A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer. PubMed. 4(2). 138–141. 51 indexed citations
8.
Adams‐Campbell, Lucile L., Chiledum Ahaghotu, Melvin Gaskins, et al.. (2004). Enrollment of African Americans Onto Clinical Treatment Trials: Study Design Barriers. Journal of Clinical Oncology. 22(4). 730–734. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026